BPC 157 promotes VEGFR2 internalization in association with VEGFR2-Akt-eNOS activation
We take note of your blood levels and feedback, using that information to determine whether to change the frequency of your treatment over time
Individuals with severe kidney failure, decompensated liver disease, congestive heart failure with fluid overload, non-ketonic hyper-glycemia, or known hypersensitivity to formulation components should not receive glycine
doi:10.1093/aje/kww212
User 15 cited a general dosing range of 2.5 to 3.75mcg per kilogram of body weight twice daily, which, at higher body weights, still produces doses within the standard 250 to 500mcg range being used across the dataset
But Ive had many patients take BPC-157 and TB-500, and it does seem to do something